Dr Lawrence and staff be will out of the office Nov 11-15, 2019 and will return Nov 18, 2019 @ 9 AM.
To All Patients:
Please realize that due to HIPPA restrictions, we are unable to reply to any social media communications (i.e., Facebook, e-mail, etc) containing ANY of your medical information. Please do not send such communiques by any of these methods, as we are unable to respond. This is to protect your privacy. Please call the office at 334-475-2058 for such concerns.—Dr. Lawrence
Effective March 1, 2019, All patients requesting refills of medications need to be seen by physician in clinic.
Effective April 1, 2019, Office hours will change to M-Th 8 am to 5 pm and Fri 8 am to 12 pm.
IMPORTANT UPDATE FOR ALL FAA APPLICANTS
As of 9 November 2017, applicants completing the FAA questionnaire on MEDXPRESS must provide detail for any questions regarding medical history.
Entries such as “previously reported” or “no change” are no longer acceptable.
Applicants upon presentation for their medical examination that have provided such response will experience significant delays in the processing of their applications, and in some cases may need to reschedule a follow up appointment, or have their application deferred.
There may be extra expenses incurred to cover the cost and time of processing incomplete applications.
Applicants may expedite their examination completion simply by providing details when preparing their MEDXPRESS forms.
Example: 18.x.Other illness, disability, or surgery:
Applicant has history of appendectomy in 1980.
Entry CANNOT read “PRNC” or “previously reported” or “no change”
Applicant must provide sufficient history to establish there is no aeromedical concern.
“Appendectomy, 1980, no complications”
NEW CHANGES IN CONTROLLED PRESCRIPTION RULES IN ALABAMA
On March 9, 2017, the Alabama Board of Medical Examiners adopted a new rule concerning the use of risk and abuse mitigation strategies for prescribing physicians. The new rule requires the use of risk and mitigation strategies (RMS) when prescribing controlled substances for the treatment of pain. The rule also notes a heightened risk of adverse events associated with concurrent use of opioids and benzodiazepines and requires that physicians reconsider existing benzodiazepine prescriptions. For the purpose of preventing controlled substance diversion, abuse, misuse, addiction, and doctor-shopping, physicians are required to adhere to monitoring requirements utilizing the Alabama Prescription Drug Monitoring Program. It is anticipated that over time, current laws may become even more restrictive. One only has to look at current laws enacted in Ohio as an example, which limit the number of days for which certain prescriptions may be written.
It is the intent of this office to comply with all rules promulgated by the State of Alabama and the Board of Medical Examiners. We recognize that this may necessitate changes to current medical therapy being received and/or consultations to other specialists, such as Pain Management, to meet the new standards while providing for pain mitigation. We regret any hardship this may create, and appreciate your understanding and cooperation during this time of transition.